SCHEMBL28761502

SCHEMBL28761502

c1ccc(CCCCCC2CCN(c3ccnc4ccccc34)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.52
ADRB2 P07550 1/20 0.49
NCF1 P14598 1/20 0.49
ACHE P22303 4/20 0.47
NMT1 P30419 1/20 0.47
F10 P00742 2/20 0.42
DRD2 P14416 3/20 0.42
DRD3 P35462 3/20 0.42
SLC18A3 Q16572 1/20 0.41
CYP2C9 P11712 1/20 0.41
PDE10A Q9Y233 1/20 0.40
DRD4 P21917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27645178 0.95 ADRB2 (0.51) KCNH2ADRB2NCF1ACHENMT1
SCHEMBL2093497 0.87 NMT1 (0.42) KCNH2ACHENMT1DRD2DRD3
SCHEMBL27645112 0.87 NMT1 (0.43) KCNH2ADRB2NCF1ACHENMT1
SCHEMBL27645182 0.87 NMT1 (0.44) KCNH2ADRB2NCF1ACHENMT1
SCHEMBL27666211 0.87 NMT1 (0.44) KCNH2ADRB2NCF1ACHENMT1
SCHEMBL2089595 0.86 NMT1 (0.46) KCNH2ADRB2NCF1ACHENMT1
SCHEMBL28761490 0.82 NMT1 (0.49) KCNH2ADRB2NCF1ACHENMT1
SCHEMBL2096547 0.79 SLC18A3 (0.41) ACHENMT1SLC18A3PDE10A
SCHEMBL27666325 0.78 KCNH2 (0.73) KCNH2ADRB2NCF1DRD2DRD3
SCHEMBL6186822 0.77 ADRB2 (0.62) KCNH2ADRB2NCF1F10DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed